Abstract
Obesity has an important impact on general health outcomes and is prevalent in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated stroke/systemic embolism (SE) and major bleeding (MB) among obese NVAF patients using non-vitamin K antagonist oral anticoagulants (NOACs) in the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
